Teladoc Reports $1B Loss in 2024, Focuses on Chronic Care and International Growth

Teladoc Health, a leading telehealth provider, has reported a $1 billion loss for the fiscal year 2024, primarily due to a significant impairment charge related to its BetterHelp mental health business. Despite this setback, the company is emphasizing its growth in chronic care management and international markets as key drivers for future success.
Financial Performance and Challenges
Teladoc's full-year 2024 revenue totaled $2.6 billion, a 1% decrease from 2023. The company's integrated care segment, which includes chronic care management, saw a 4% increase in revenue to $1.5 billion. However, the BetterHelp segment experienced an 8% revenue decline to $1 billion.
The substantial loss was largely attributed to a $790 million goodwill impairment charge in the second quarter, related to the BetterHelp business. This charge reflects changes in estimates of future cash flows for the direct-to-consumer mental health platform.
In the fourth quarter, Teladoc reported revenue of $640.5 million, down 3% year-over-year, with a net loss of $48.4 million. The company's adjusted EBITDA for Q4 decreased by 35% to $75 million compared to the same period in 2023.
Strategic Focus on Chronic Care and International Expansion
Despite the financial challenges, Teladoc is positioning itself for growth in key areas:
-
Chronic Care Management: The company is leveraging its recent acquisition of Catapult Health to enhance its chronic condition management capabilities. Chuck Divita, CEO of Teladoc Health, highlighted the potential synergies between Catapult's preventive care services and Teladoc's existing programs.
-
International Growth: Teladoc reported a 10% increase in international revenue in Q4, with full-year international revenue growing by 12%. The company plans to expand its localized BetterHelp offerings in Europe as part of its international strategy.
-
New Partnerships: Teladoc has secured a contract with TRICARE and is exploring new partnerships to support its growth initiatives. The company also teased a new feature that will allow for efficient integration with external ecosystem partners.
Outlook and Guidance for 2025
Looking ahead, Teladoc provided guidance for 2025, projecting revenue between $2.47 billion to $2.58 billion, which represents flat to slightly declining growth. The company expects adjusted EBITDA of $278 million to $319 million for the full year 2025.
Teladoc aims to stabilize its BetterHelp business by monitoring customer acquisition costs and improving the platform's user experience. The company will continue to experiment with pricing models, building on the weekly pricing strategy introduced in 2024.
As Teladoc navigates a complex healthcare market impacted by factors such as medical cost inflation and regulatory changes, it remains committed to leveraging virtually-enabled care to support customer needs and drive long-term success.
References
- Teladoc reports $1B loss in 2024, driven by BetterHelp Q2 impairment charge
Teladoc released its full-year 2024 earnings on Wednesday. Executives touted the growth of the chronic care management segment and international success. The company is still trying to course correct on BetterHelp.
Explore Further
What are the strategic reasons behind Teladoc Health's focus on chronic care management for future growth?
How does Teladoc plan to address the challenges faced by its BetterHelp segment, particularly in terms of customer acquisition costs?
What impact might Teladoc's international growth strategy and partnerships have on its overall financial performance in the coming years?
How is Teladoc's recent acquisition of Catapult Health expected to enhance its chronic care management capabilities?
What are the main factors contributing to the projected flat to slightly declining growth in Teladoc's revenue for 2025?